Shariat SF, Laukhtina E. Re: Gemcitabine and Cisplatin plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial. Galsky MD, Daneshmand S, Izadmehr S, et al. Nat Med 2023;29:2825-34. Eur Urol 2024 Feb 14:S0302-2838(24)00066-6. doi: 10.1016/j.eururo.2024.
PMID: 38360442